Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Hadassah’s Internal Medicine Department: A Holistic Approach to Patient Care with Research a Premier Priority

Prof. Yaakov Naparstek, Chair of Medicine

A multidisciplinary, holistic approach to patient care, combined with a large number of physician/scientists who take care of patients and conduct their own research are hallmarks of the Hadassah Medical Center's Internal Medicine department.

Its chair is Prof. Yaakov Naparstek, who was recently named Executive Deputy Director General of Research and Academics. As he notes, Internal Medicine is his professional project of which he is very proud. Hadassah's physician/scientists, he brings out, understand both the natural processes of the human body as a scientist would, as well as the disease as it clinically manifests itself--the way a physician would. Physician/scientists translate research they conduct in the laboratory into treatments for their patients. Therefore, he relates, they have a "unique role in developing new therapies." Personally, Prof. Naparstek notes, he believes that being a scientist makes him a better physician and being a physician makes him a better scientist.

Prof. Naparstek has always been particularly drawn to examine the functioning of the immune system and what causes it to become pathological--what causes autoimmune diseases. "I wanted to understand it; I wanted to solve it," he says. Prof. Naparstek is currently investigating lupus, which frequently affects young women. The inflammation that results from this autoimmune disease, he explains, is typically treated with drugs like corticosteroids, which suppress the immune system. His research revolves around investigating the "bad antibodies" that cause the disesase and how to remove just those antibodies and leave the good ones intact.

The Institute of General Medicine comprises thirteen departments and nine Centers of Excellence. Each a leader in its field, the Centers include the Unit for the Early Detection of Colorectal Cancer, Center for Aging Research, National Center for Down Syndrome, and National SLE (LUPUS) Center. Its stellar Intensive Care Unit is world renowned.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas

"While many people in the medical world ask why some people develop rheumatoid arthritis, at Hadassah," Prof. Naparstek says, "we ask why most people do not get the disease." Following this line of thinking, Hadassah looks into treatment which will replicate natural processes that keep people healthy.

Using animal models, Hadassah's physician/scientists study the protective antibodies that prevent the animal from getting arthritis. They are now performing clinical trials using protective antibodies they have created through genetic engineering and various sophisticated molecular techniques, not only with patients who have rheumatoid arthritis, but also with individuals who have other inflammatory diseases such as Crohn's and ulcerative colitis.

Plans are for the Internal Medicine Department to move into the Sarah Wetsman Davidson Hospital Tower in the spring of 2014. The new structure of the intensive care units—three intermediate ones for each of the three inpatient care departments and a fourth medical intensive care unit for more critically ill patients all in one suite--will enable the staff to work more in tandem and help one another. In addition, Prof. Naparstek says, the spacious new two-patient rooms, with privacy for each patient, will make doctor visits more comfortable for both the patient and the family and allow for more procedures to be performed at the patient's bedside.

The first member of his family to become a physician, Prof. Naparstek has been at Hadassah for 40 years. He met his wife, a hematologist, while they were both medical students at the Hadassah-Hebrew University School of Medicine. Together, when they were young physicians, they performed the first bone marrow transplantation in Israel. Prof. Naparstek, who served as a visiting professor and research fellow at the National Institutes of Health in Bethesda (Maryland), Tufts University (Massachusetts), and Stanford University (California), views donors around the world as part of his family--a family that has the same vision he has: to have the best medical treatment possible for Hadassah's patients and the best modern medical research.

Date: 9/9/2013

Educational Conference in Israel Marks World Down Syndrome Day

Hadassah Medical Organization and Berlin’s Charité University Hospital Sign Cooperation Agreement for Pediatrics and Neuroscience

Insight into Pediatric Radiotherapy Treatment at Hadassah Provided to ALYN Colleagues

Hadassah Pioneer of Open Heart Surgery and Heart Transplants Shares Autobiography

UK Prime Minister Briefed on Israel-UK Collaborative Stem Cell Research

Purim Brings a Party to Pediatrics

Purim in Pediatrics

Snapshots: Three Patients in the Neuro ICU

Volunteers Deliver Dose of Happiness to Hadassah Patients on "Good Deeds Day"

Wounded by Gunfire, Ukranians Airlifted to Hadassah

Hadassah Motivates Israel’s Government to Campaign for Women’s Heart Health

330,000 Mazal Tovs

Swedish Delegation Makes a Visit

Hadassah’s HIV/AIDS Experts Host Psychosocial Workshop in Addis Ababa for Orphanage Staff

Hadassah's Fertility Expert Caters to Hopeful Potential Parents with New Clinic

Using the Power of Music Therapy at Hadassah Medical Organization

Deep Sequencing Analysis Leads to Major Genetic Discoveries at Hadassah

US Cannabis Activist Meets Hadassah’s Cannabis Research Pioneer

First Neurology Patients Move in to Hadassah's Hospital Tower

Hadassah Researchers Use Functional MRI to Detect Responsiveness in Unconscious Patients



More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America